- Home
- TECH vs RVPH Comparison
TECH vs RVPH Comparison
Compare TECH & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TECH
- RVPH
- Stock Information
- Founded
- TECH 1976
- RVPH 2006
- Country
- TECH United States
- RVPH United States
- Employees
- TECH N/A
- RVPH N/A
- Industry
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- RVPH Biotechnology: Pharmaceutical Preparations
- Sector
- TECH Health Care
- RVPH Health Care
- Exchange
- TECH Nasdaq
- RVPH Nasdaq
- Market Cap
- TECH 8.0B
- RVPH N/A
- IPO Year
- TECH 1989
- RVPH N/A
- Fundamental
- Price
- TECH $50.78
- RVPH $0.90
- Analyst Decision
- TECH Buy
- RVPH Strong Buy
- Analyst Count
- TECH 8
- RVPH 5
- Target Price
- TECH $81.14
- RVPH $10.00
- AVG Volume (30 Days)
- TECH 2.3M
- RVPH 954.9K
- Earning Date
- TECH 05-07-2025
- RVPH 05-13-2025
- Dividend Yield
- TECH 0.63%
- RVPH N/A
- EPS Growth
- TECH N/A
- RVPH N/A
- EPS
- TECH 0.98
- RVPH N/A
- Revenue
- TECH $1,196,016,000.00
- RVPH N/A
- Revenue This Year
- TECH $8.19
- RVPH N/A
- Revenue Next Year
- TECH $8.85
- RVPH N/A
- P/E Ratio
- TECH $51.85
- RVPH N/A
- Revenue Growth
- TECH 4.46
- RVPH N/A
- 52 Week Low
- TECH $46.44
- RVPH $0.49
- 52 Week High
- TECH $85.57
- RVPH $4.28
- Technical
- Relative Strength Index (RSI)
- TECH 42.06
- RVPH 52.83
- Support Level
- TECH $46.01
- RVPH $0.70
- Resistance Level
- TECH $53.54
- RVPH $0.81
- Average True Range (ATR)
- TECH 3.36
- RVPH 0.10
- MACD
- TECH 0.19
- RVPH 0.05
- Stochastic Oscillator
- TECH 57.33
- RVPH 96.33
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.